Annemarie N. Van Der Meij
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.
Journal: Journal of psychiatric research
Published: July 16, 2025
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.
Journal: Journal of psychopharmacology (Oxford, England)
Published: April 26, 2025
Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 25, 2024
Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension.
Journal: Molecular psychiatry
Published: September 20, 2023
Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial.
Journal: JAMA network open
Published: May 08, 2023
The perceived waning of biologics in severe asthma.
Journal: Respiratory medicine
Published: April 07, 2023
BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuse.
Journal: Psychoneuroendocrinology
Published: October 16, 2013
Never-depressed females with a family history of depression demonstrate affective bias.
Journal: Psychiatry research
Published: February 23, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026